Abstract
Recently, we reported that heparanase plays important roles in barrier-disrupted skin, leading to increased interaction of growth factors between epidermis and dermis and facilitating various cutaneous changes, including epidermal hyperplasia and wrinkle formation. However, the role of heparanase in sun-exposed skin remains unknown. Here, we show that heparanase in human keratinocytes is activated by ultraviolet B (UVB) exposure and that heparan sulfate of perlecan is markedly degraded in UVB-irradiated human skin. The degradation of heparan sulfate resulted in a marked reduction of binding activity of the basement membrane for vascular endothelial growth factor, fibroblast growth factor-2 and -7 at the dermal–epidermal junction. Degradation of heparan sulfate was observed not only in acutely UVB-irradiated skin, but also in skin chronically exposed to sun. Interestingly, heparan sulfate was found to be degraded in sun-exposed skin, but not in sun-protected skin. These findings suggest that chronic UVB exposure activates heparanase, leading to degradation of heparan sulfate in the basement membrane and increased growth factor interaction between epidermis and dermis. These changes may facilitate photo-aging.
Similar content being viewed by others
Abbreviations
- TEWL:
-
Transepidermal water loss
- UVB:
-
Ultraviolet B
- VEGF:
-
Vascular endothelial growth factor
- FGF:
-
Fibroblast growth factor
- HS:
-
Heparan sulfate
- HSPGs:
-
Heparan sulfate proteoglycans
- MED:
-
Minimal erythema dose
- DEJ:
-
Dermal epidermal junction(s)
- MMP:
-
Matrix metalloproteinase
- ATP:
-
Adenosine triphosphate
References
Abboud-Jarrous G, Atzmon R, Peretz T, Palermo C, Gadea BB, Joyce JA, Vlodavsky I (2008) Cathepsin L is responsible for processing and activation of proheparanase through multiple cleavages of a linker segment. J Biol Chem 283(26):18167–18176
Ashikari-Hada S, Habuchi H, Kariya Y, Itoh N, Reddi AH, Kimata K (2004) Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library. J Biol Chem 279(13):12346–12354
Behzad F, Brenchley PE (2003) A multiwell format assay for heparanase. Anal Biochem 320(2):207–213
Bernard D, Mehul B, Delattre C, Simonetti L, Thomas-Collignon A, Schmidt R (2001) Purification and characterization of the endoglycosidase heparanase 1 from human plantar stratum corneum: a key enzyme in epidermal physiology? J Investig Dermatol 117(5):1266–1273
Campbell EJ, Owen CA (2007) The sulfate groups of chondroitin sulfate- and heparan sulfate-containing proteoglycans in neutrophil plasma membranes are novel binding sites for human leukocyte elastase and cathepsin G. J Biol Chem 282(19):14645–14654
Chung JH, Yano K, Lee MK, Youn CS, Seo JY, Kim KH, Cho KH, Eun HC, Detmar M (2002) Differential effects of photoaging vs intrinsic aging on the vascularization of human skin. Arch Dermatol 138(11):1437–1442
Detmar M, Yeo KT, Nagy JA, Van de Water L, Brown LF, Berse B, Elicker BM, Ledbetter S, Dvorak HF (1995) Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Investig Dermatol 105(1):44–50
Elkin M, Ilan N, Ishai-Michaeli R, Friedmann Y, Papo O, Pecker I, Vlodavsky I (2001) Heparanase as mediator of angiogenesis: mode of action. Faseb J 15(9):1661–1663
Freeman C, Liu L, Banwell MG, Brown KJ, Bezos A, Ferro V, Parish CR (2005) Use of sulfated linked cyclitols as heparan sulfate mimetics to probe the heparin/heparan sulfate binding specificity of proteins. J Biol Chem 280(10):8842–8849
Freeman C, Parish CR (1998) Human platelet heparanase: purification, characterization and catalytic activity. Biochem J 330(Pt 3):1341–1350
Friedl A, Chang Z, Tierney A, Rapraeger AC (1997) Differential binding of fibroblast growth factor-2 and -7 to basement membrane heparan sulfate: comparison of normal and abnormal human tissues. Am J Pathol 150(4):1443–1455
Fuki II, Iozzo RV, Williams KJ (2000) Perlecan heparan sulfate proteoglycan. A novel receptor that mediates a distinct pathway for ligand catabolism. J Biol Chem 275(40):31554
Gilchrest BA (1989) Skin aging and photoaging: an overview. J Am Acad Dermatol 21(3 Pt 2):610–613
Gingis-Velitski S, Ishai-Michaeli R, Vlodavsky I, Ilan N (2007) Anti-heparanase monoclonal antibody enhances heparanase enzymatic activity and facilitates wound healing. Faseb J 21(14):3986–3993
Griffiths CE (1992) The clinical identification and quantification of photodamage. Br J Dermatol 127(Suppl 41):37–42
Inoue K, Hosoi J, Denda M (2007) Extracellular ATP has stimulatory effects on the expression and release of IL-6 via purinergic receptors in normal human epidermal keratinocytes. J Investig Dermatol 127(2):362–371
Iozzo RV (2005) Basement membrane proteoglycans: from cellar to ceiling. Nat Rev 6(8):646–656
Iriyama S, Matsunaga Y, Amano S (2010) Heparanase activation induces epidermal hyperplasia, angiogenesis, lymphangiogenesis and wrinkles. Exp Dermatol 19(11):965–972
Kadoya K, Sasaki T, Kostka G, Timpl R, Matsuzaki K, Kumagai N, Sakai LY, Nishiyama T, Amano S (2005) Fibulin-5 deposition in human skin: decrease with ageing and ultraviolet B exposure and increase in solar elastosis. Br J Dermatol 153(3):607–612
Kajiya K, Hirakawa S, Detmar M (2006) Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel function. Am J Pathol 169(4):1496–1503
Kajiya K, Kunstfeld R, Detmar M, Chung JH (2007) Reduction of lymphatic vessels in photodamaged human skin. J Dermatol Sci 47(3):241–243
Kan M, Wu X, Wang F, McKeehan WL (1999) Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase. J Biol Chem 274(22):15947–15952
Kato M, Wang H, Kainulainen V, Fitzgerald ML, Ledbetter S, Ornitz DM, Bernfield M (1998) Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2. Nat Med 4(6):691–697
Kobayashi M, Naomoto Y, Nobuhisa T, Okawa T, Takaoka M, Shirakawa Y, Yamatsuji T, Matsuoka J, Mizushima T, Matsuura H, Nakajima M, Nakagawa H, Rustgi A, Tanaka N (2006) Heparanase regulates esophageal keratinocyte differentiation through nuclear translocation and heparan sulfate cleavage. Differ Res Biol Divers 74(5):235–243
Koyama Y, Naruo H, Yoshitomi Y, Munesue S, Kiyono S, Kusano Y, Hashimoto K, Yokoi T, Nakanishi H, Shimizu S, Okayama M, Oguri K (2008) Matrix metalloproteinase-9 associated with heparan sulphate chains of GPI-anchored cell surface proteoglycans mediates motility of murine colon adenocarcinoma cells. J Biochem 143(5):581–592
Kreuger J, Salmivirta M, Sturiale L, Gimenez-Gallego G, Lindahl U (2001) Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. J Biol Chem 276(33):30744–30752
Lavker RM (1979) Structural alterations in exposed and unexposed aged skin. J Investig Dermatol 73(1):59–66
Lindner JR, Hillman PR, Barrett AL, Jackson MC, Perry TL, Park Y, Datta S (2007) The Drosophila Perlecan gene trol regulates multiple signaling pathways in different developmental contexts. BMC Dev Biol 7:121
Luo Y, Ye S, Kan M, McKeehan WL (2006) Control of fibroblast growth factor (FGF) 7- and FGF1-induced mitogenesis and downstream signaling by distinct heparin octasaccharide motifs. J Biol Chem 281(30):21052–21061
Maas-Szabowski N, Shimotoyodome A, Fusenig NE (1999) Keratinocyte growth regulation in fibroblast cocultures via a double paracrine mechanism. J Cell Sci 112(Pt 12):1843–1853
Malgouries S, Donovan M, Thibaut S, Bernard BA (2008) Heparanase 1: a key participant of inner root sheath differentiation program and hair follicle homeostasis. Exp Dermatol 17(12):1017–1023
Nakajima M, Irimura T, Di Ferrante N, Nicolson GL (1984) Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. J Biol Chem 259(4):2283–2290
Parish CR, Freeman C, Hulett MD (2001) Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta 1471(3):M99–M108
Patel VN, Knox SM, Likar KM, Lathrop CA, Hossain R, Eftekhari S, Whitelock JM, Elkin M, Vlodavsky I, Hoffman MP (2007) Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis. Development (Cambridge, England) 134(23):4177–4186
Perrimon N, Bernfield M (2000) Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404(6779):725–728
Pikas DS, Li JP, Vlodavsky I, Lindahl U (1998) Substrate specificity of heparanases from human hepatoma and platelets. J Biol Chem 273(30):18770–18777
Purushothaman A, Chen L, Yang Y, Sanderson RD (2008) Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma. J Biol Chem 283(47):32628–32636
Reiland J, Sanderson RD, Waguespack M, Barker SA, Long R, Carson DD, Marchetti D (2004) Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion. J Biol Chem 279(9):8047–8055
Reinheckel T, Hagemann S, Dollwet-Mack S, Martinez E, Lohmuller T, Zlatkovic G, Tobin DJ, Maas-Szabowski N, Peters C (2005) The lysosomal cysteine protease cathepsin L regulates keratinocyte proliferation by control of growth factor recycling. J Cell Sci 118(Pt 15):3387–3395
Shafat I, Vlodavsky I, Ilan N (2006) Characterization of mechanisms involved in secretion of active heparanase. J Biol Chem 281(33):23804–23811
Spencer JL, Stone PJ, Nugent MA (2006) New insights into the inhibition of human neutrophil elastase by heparin. Biochemistry 45(30):9104–9120
Tammela T, He Y, Lyytikka J, Jeltsch M, Markkanen J, Pajusola K, Yla-Herttuala S, Alitalo K (2007) Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins. Circ Res 100(10):1468–1475
Vlodavsky I, Friedmann Y (2001) Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Investig 108(3):341–347
Vlodavsky I, Miao HQ, Medalion B, Danagher P, Ron D (1996) Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev 15(2):177–186
Whitelock JM, Iozzo RV (2005) Heparan sulfate: a complex polymer charged with biological activity. Chem Rev 105(7):2745–2764
Yano K, Kadoya K, Kajiya K, Hong YK, Detmar M (2005) Ultraviolet B irradiation of human skin induces an angiogenic switch that is mediated by upregulation of vascular endothelial growth factor and by downregulation of thrombospondin-1. Br J Dermatol 152(1):115–121
Zcharia E, Zilka R, Yaar A, Yacoby-Zeevi O, Zetser A, Metzger S, Sarid R, Naggi A, Casu B, Ilan N, Vlodavsky I, Abramovitch R (2005) Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models. Faseb J 19(2):211–221
Acknowledgments
We thank Junko Hatori for expert technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iriyama, S., Matsunaga, Y., Takahashi, K. et al. Activation of heparanase by ultraviolet B irradiation leads to functional loss of basement membrane at the dermal–epidermal junction in human skin. Arch Dermatol Res 303, 253–261 (2011). https://doi.org/10.1007/s00403-010-1117-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-010-1117-5